Further studies revealed that prostaglandin (PG) E2 boosted NSCLC cell proliferation via upregulating the AKT/protein kinase B pathway, while PGE3 suppressed this pathway.58 This evidence concerns the gene AKT1 and non-small cell lung carcinoma.